Skip to content

Pfenex Inc.

Delisted

CIK 1478121fmd_0B8VXSYTZRP19KVP1A40FV2XEDManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2012 to Jun 30, 2020, 31 periods

Latest annual · FY2019

Millions
Total revenues
50
Gross profit
45
Operating income
1
Net income
1
Free cash flow
(6)

Latest quarter · Q2 FY2020

Millions
Total revenues
1
Gross profit
0
Operating income
(10)
Net income
(10)
Free cash flow
(5)
Open Financials

Key stats

Open Analysis

Compound annual growth

Revenue, 3 yearsFY2016 to FY2019
-5.8%
Revenue, 5 yearsFY2014 to FY2019
+36.4%
Net income, 5 yearsFY2014 to FY2019
n/m

Pfenex Inc. financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2019FY2018ChangeSource
Revenue$50.3 million$14.9 million+238.7%10-K 2020-03-11 · proof
Gross profit$45.4 million$9.8 million+362%10-K 2020-03-11 · proof
Operating income$824,000-$39.9 million10-K 2020-03-11 · proof
Net income$1.1 million-$39.6 million10-K 2020-03-11 · proof
Cash from operating activities-$4.1 million-$39.4 million10-K 2020-03-11 · proof
Free cash flow-$5.6 million-$40.9 million10-K 2020-03-11 · proof
Total assets$84.9 million$81.3 million+4.4%10-K 2020-03-11 · proof
Total liabilities$12.6 million$20.1 million-37.5%10-K 2020-03-11 · proof
Cash and cash equivalents$55.6 million$56.2 million-1.1%10-K 2020-03-11 · proof
What was Pfenex Inc.'s revenue in fiscal 2019?
Pfenex Inc. reported revenue of $50.3 million for fiscal 2019 (the year ended Dec 31, 2019), against $14.9 million the year before (+238.7%). Source: the 10-K filed with the SEC on Mar 11, 2020. SEC
What was Pfenex Inc.'s gross profit in fiscal 2019?
Pfenex Inc. reported gross profit of $45.4 million for fiscal 2019 (the year ended Dec 31, 2019), against $9.8 million the year before (+362%). Source: the 10-K filed with the SEC on Mar 11, 2020. SEC
What was Pfenex Inc.'s operating income in fiscal 2019?
Pfenex Inc. reported operating income of $824,000 for fiscal 2019 (the year ended Dec 31, 2019), against -$39.9 million the year before. Source: the 10-K filed with the SEC on Mar 11, 2020. SEC
What was Pfenex Inc.'s net income in fiscal 2019?
Pfenex Inc. reported net income of $1.1 million for fiscal 2019 (the year ended Dec 31, 2019), against -$39.6 million the year before. Source: the 10-K filed with the SEC on Mar 11, 2020. SEC
What was Pfenex Inc.'s cash from operating activities in fiscal 2019?
Pfenex Inc. reported cash from operating activities of -$4.1 million for fiscal 2019 (the year ended Dec 31, 2019), against -$39.4 million the year before. Source: the 10-K filed with the SEC on Mar 11, 2020. SEC
What was Pfenex Inc.'s free cash flow in fiscal 2019?
Pfenex Inc. reported free cash flow of -$5.6 million for fiscal 2019 (the year ended Dec 31, 2019), against -$40.9 million the year before. Source: the 10-K filed with the SEC on Mar 11, 2020. SEC
What are Pfenex Inc.'s total assets?
As of Dec 31, 2019, Pfenex Inc. reported total assets of $84.9 million, against $81.3 million a year earlier (+4.4%). Source: the 10-K filed with the SEC on Mar 11, 2020. SEC
What are Pfenex Inc.'s total liabilities?
As of Dec 31, 2019, Pfenex Inc. reported total liabilities of $12.6 million, against $20.1 million a year earlier (-37.5%). Source: the 10-K filed with the SEC on Mar 11, 2020. SEC
What are Pfenex Inc.'s cash and cash equivalents?
As of Dec 31, 2019, Pfenex Inc. reported cash and cash equivalents of $55.6 million, against $56.2 million a year earlier (-1.1%). Source: the 10-K filed with the SEC on Mar 11, 2020. SEC

Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1478121&period_type=annual&limit=5"

Information only, not investment advice.